http://orcid.org/0000-0003-2613-1669
Citations (106)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Ileana García-Silva, Dania O Govea-Alonso & Sergio Rosales-Mendoza. (2023) Current status of mucosal vaccines against SARS-CoV2: a hope for protective immunity. Expert Opinion on Biological Therapy 23:2, pages 207-222.
Read now
Read now
Hunter McFall-Boegeman & Xuefei Huang. (2022) Mechanisms of cellular and humoral immunity through the lens of VLP-based vaccines. Expert Review of Vaccines 21:4, pages 453-469.
Read now
Read now
Amrita Das & Nahid Ali. (2021) Nanovaccine: an emerging strategy. Expert Review of Vaccines 20:10, pages 1273-1290.
Read now
Read now
Christopher P. Karch & Gary R. Matyas. (2021) The current and future role of nanovaccines in HIV-1 vaccine development. Expert Review of Vaccines 20:8, pages 935-944.
Read now
Read now
Rahul Shukla, Viswanathan Ramasamy, Ravi Kant Rajpoot, Upasana Arora, Ankur Poddar, Richa Ahuja, Hemalatha Beesetti, Sathyamangalam Swaminathan & Navin Khanna. (2019) Next generation designer virus-like particle vaccines for dengue. Expert Review of Vaccines 18:2, pages 105-117.
Read now
Read now
Articles from other publishers (101)
Ryo Okuyama. (2023) mRNA and Adenoviral Vector Vaccine Platforms Utilized in COVID-19 Vaccines: Technologies, Ecosystem, and Future Directions. Vaccines 11:12, pages 1737.
Crossref
Crossref
Fabian G. Martinez, Ryszard A. Zielke, Cyrielle E. Fougeroux, Lixin Li, Adam F. Sander & Aleksandra E. Sikora. (2023)
Development of a Tag/Catcher-mediated capsid virus-like particle vaccine presenting the conserved
Neisseria gonorrhoeae
SliC antigen that blocks human lysozyme
. Infection and Immunity.
Crossref
Crossref
Xanthippi Topalidou, Alexis M. Kalergis & Georgios Papazisis. (2023) Respiratory Syncytial Virus Vaccines: A Review of the Candidates and the Approved Vaccines. Pathogens 12:10, pages 1259.
Crossref
Crossref
Ruoman Bai, Mingzhu Li, Zhanyun Tian, Yiming Hu, Manxin An, Wanzhe Yuan & Limin Li. (2023) Nanoparticulate chitosan-TNF-α-VLPs activate mast cells and enhance adaptive immunity induced by foot-and-mouth disease virus-like particles in mice. Veterinary Immunology and Immunopathology 264, pages 110662.
Crossref
Crossref
Rocio Mellid-Carballal, Sara Gutierrez-Gutierrez, Carmen Rivas & Marcos Garcia-Fuentes. (2023) Viral protein-based nanoparticles (part 2): Pharmaceutical applications. European Journal of Pharmaceutical Sciences 189, pages 106558.
Crossref
Crossref
Büşra Ahata & Günseli Bayram Akçapınar. (2023) CCHFV vaccine development, current challenges, limitations, and future directions. Frontiers in Immunology 14.
Crossref
Crossref
Luis Giovani Oliveira Guardalini, Vinícius Aragão Tejo Dias, Jaci Leme, Thaissa Consoni Bernardino, Renato Mancini Astray, Suellen Regina da Silveira, Paulo Lee Ho, Aldo Tonso, Soraia Attie Calil Jorge & Eutimio Gustavo Fernández Núñez. (2023) Comparison of chemometric models using Raman spectroscopy for offline biochemical monitoring throughout the VLP-making upstream process. Biochemical Engineering Journal 198, pages 109013.
Crossref
Crossref
Chittaranjan Baruah, Pankaj Das, Papari Devi, Palash Moni Saikia & Bhabesh Deka. (2023) The emergence of nanovaccines as a new paradigm in virological vaccinology: a review. Exploration of Immunology, pages 361-383.
Crossref
Crossref
Xinyue Lu, Miaomiao Zhang, Ge Li, Shixin Zhang, Jingbo Zhang, Xiaoge Fu & Fengying Sun. (2023) Applications and Research Advances in the Delivery of CRISPR/Cas9 Systems for the Treatment of Inherited Diseases. International Journal of Molecular Sciences 24:17, pages 13202.
Crossref
Crossref
Rocio Mellid-Carballal, Sara Gutierrez-Gutierrez, Carmen Rivas & Marcos Garcia-Fuentes. (2023) Viral protein nanoparticles (Part 1): Pharmaceutical characteristics. European Journal of Pharmaceutical Sciences 187, pages 106460.
Crossref
Crossref
Emma R. Sudduth, Michael Trautmann-Rodriguez, Nicole Gill, Kartik Bomb & Catherine A. Fromen. (2023) Aerosol pulmonary immune engineering. Advanced Drug Delivery Reviews 199, pages 114831.
Crossref
Crossref
Jaci Leme, Luis Giovani Oliveira Guardalini, Thaissa Consoni Bernardino, Renato Mancini Astray, Aldo Tonso, Eutimio Gustavo Fernández Núñez & Soraia Attie Calil Jorge. (2022) Sf9 Cells Metabolism and Viability When Coinfected with Two Monocistronic Baculoviruses to Produce Rabies Virus-like Particles. Molecular Biotechnology 65:6, pages 970-982.
Crossref
Crossref
Ernesto Garay, Diego Fontana, Javier Villarraza, Antonela Fuselli, Agustina Gugliotta, Sebastián Antuña, Belén Tardivo, María Celeste Rodríguez, Victoria Gastaldi, Juan Manuel Battagliotti, Diego Alvarez, Eliana Castro, Juliana Cassataro, Natalia Ceaglio & Claudio Prieto. (2023) Design and characterization of chimeric Rabies-SARS-CoV-2 virus-like particles for vaccine purposes. Applied Microbiology and Biotechnology 107:11, pages 3495-3508.
Crossref
Crossref
Mingyang Liu, Yan Zhao, Zhishang Shi, Jeffrey I. Zink & Qilin Yu. (2023) Virus-like Magnetic Mesoporous Silica Particles as a Universal Vaccination Platform against Pathogenic Infections. ACS Nano 17:7, pages 6899-6911.
Crossref
Crossref
Shiv Swaroop, Nidhi Verma, Jay Kant Yadav & Janmejay Pandey. 2023. Current Trends in the Identification and Development of Antimicrobial Agents. Current Trends in the Identification and Development of Antimicrobial Agents
1
27
.
Ali A. Rabaan, Shamsah H. Al-Ahmed, Hawra Albayat, Sara Alwarthan, Mashael Alhajri, Mustafa A. Najim, Bashayer M. AlShehail, Wasl Al-Adsani, Ali Alghadeer, Wesam A. Abduljabbar, Nouf Alotaibi, Jameela Alsalman, Ali H. Gorab, Reem S. Almaghrabi, Ali A. Zaidan, Sahar Aldossary, Mohammed Alissa, Lamees M. Alburaiky, Fatimah Mustafa Alsalim, Nanamika Thakur, Geetika Verma & Manish Dhawan. (2023) Variants of SARS-CoV-2: Influences on the Vaccines’ Effectiveness and Possible Strategies to Overcome Their Consequences. Medicina 59:3, pages 507.
Crossref
Crossref
Tianyu Shi, Mengna Sun, Changchang Lu & Fanyan Meng. (2023) Self-assembled nanoparticles: A new platform for revolutionizing therapeutic cancer vaccines. Frontiers in Immunology 14.
Crossref
Crossref
Yunes Panahi, Armita Mahdavi Gorabi, Sona Talaei, Fatemeh Beiraghdar, Abolfazl Akbarzadeh, Vahideh Tarhriz & Hassan Mellatyar. (2023) An overview on the treatments and prevention against COVID-19. Virology Journal 20:1.
Crossref
Crossref
Shuxiong Chen, Saranya Pounraj, Nivethika Sivakumaran, Anjali Kakkanat, Gayathri Sam, Md. Tanvir Kabir & Bernd H. A. Rehm. (2023) Precision-engineering of subunit vaccine particles for prevention of infectious diseases. Frontiers in Immunology 14.
Crossref
Crossref
Lei Zhang, Wen Xu, Xi Ma, XiaoJing Sun, JinBo Fan & Yang Wang. (2023) Virus-like Particles as Antiviral Vaccine: Mechanism, Design, and Application. Biotechnology and Bioprocess Engineering 28:1, pages 1-16.
Crossref
Crossref
Jorge Armero-Gimenez, Ruud Wilbers, Arjen Schots, Charles Williams & Ricarda Finnern. (2023) Rapid screening and scaled manufacture of immunogenic virus-like particles in a tobacco BY-2 cell-free protein synthesis system. Frontiers in Immunology 14.
Crossref
Crossref
Anastasiia S. Obozina, Elena N. Komedchikova, Olga A. Kolesnikova, Anna M. Iureva, Vera L. Kovalenko, Fedor A. Zavalko, Tatiana V. Rozhnikova, Ekaterina D. Tereshina, Elizaveta N. Mochalova & Victoria O. Shipunova. (2023) Genetically Encoded Self-Assembling Protein Nanoparticles for the Targeted Delivery In Vitro and In Vivo. Pharmaceutics 15:1, pages 231.
Crossref
Crossref
Santiago M.C. Lopez, Alice I. Sato & Archana Chatterjee. 2023. Viral, Parasitic, Bacterial, and Fungal Infections. Viral, Parasitic, Bacterial, and Fungal Infections
699
717
.
Cordin ArpagausCordin Arpagaus. 2023. Spray Drying of Vaccines. Spray Drying of Vaccines
325
530
.
Cordin ArpagausCordin Arpagaus. 2023. Spray Drying of Vaccines. Spray Drying of Vaccines
1
32
.
Mona Sadeghalvad, Amir Hossein Mansourabadi, Maryam Noori, Seyed Aria Nejadghaderi, Masoomeh Masoomikarimi, Masoumeh Alimohammadi & Nima Rezaei. (2022) Recent developments in SARS‐CoV‐2 vaccines: A systematic review of the current studies. Reviews in Medical Virology 33:1.
Crossref
Crossref
Luis Giovani Oliveira Guardalini, Paulo Eduardo da Silva Cavalcante, Jaci Leme, Renata Gois de Mello, Thaissa Consoni Bernardino, Simone Gonçalves Silva Jared, Marta Maria Antoniazzi, Renato Mancini Astray, Aldo Tonso, Eutimio Gustavo Fernández Núñez & Soraia Attie Calil Jorge. (2022) Performance Comparison of Recombinant Baculovirus and Rabies Virus-like Particles production Using Two Culture Platforms. Vaccines 11:1, pages 39.
Crossref
Crossref
Doddy Irawan Setyo Utomo, Sabar Pambudi & Enoch Y. Park. (2022) Humoral immune response induced with dengue virus-like particles serotypes 1 and 4 produced in silkworm. AMB Express 12:1.
Crossref
Crossref
Zhiyun Liao, Jing Huang, Pui-Chi Lo, Jonathan F. Lovell, Honglin Jin & Kunyu Yang. (2022) Self-adjuvanting cancer nanovaccines. Journal of Nanobiotechnology 20:1.
Crossref
Crossref
Jeong In Yang & Ki Hong Kim. (2022) Display of Streptococcus iniae α-Enolase on the Surface of Virus-Like Particles (VLPs) of Nervous Necrosis Virus (NNV) Using SpyTag/SpyCatcher. Marine Biotechnology 24:6, pages 1066-1072.
Crossref
Crossref
Agustín Valenzuela-Fernández, Romina Cabrera-Rodriguez, Laura Ciuffreda, Silvia Perez-Yanes, Judith Estevez-Herrera, Rafaela González-Montelongo, Julia Alcoba-Florez, Rodrigo Trujillo-González, Diego García-Martínez de Artola, Helena Gil-Campesino, Oscar Díez-Gil, José M. Lorenzo-Salazar, Carlos Flores & Jonay Garcia-Luis. (2022) Nanomaterials to combat SARS-CoV-2: Strategies to prevent, diagnose and treat COVID-19. Frontiers in Bioengineering and Biotechnology 10.
Crossref
Crossref
Rajashri Bezbaruah, Vivek P. Chavda, Lawandashisha Nongrang, Shahnaz Alom, Kangkan Deka, Tutumoni Kalita, Farak Ali, Bedanta Bhattacharjee & Lalitkumar Vora. (2022) Nanoparticle-Based Delivery Systems for Vaccines. Vaccines 10:11, pages 1946.
Crossref
Crossref
Alexandre B. Murad, Marcos Q. Sousa, Ricardo Correia, Inês A. Isidro, Manuel J. T. Carrondo & António Roldão. (2022) Targeted Metabolic Analysis and MFA of Insect Cells Expressing Influenza HA-VLP. Processes 10:11, pages 2283.
Crossref
Crossref
Heng Choon CheongYi Ying CheokYee Teng ChanSofiah SulaimanChung Yeng LooiAhmed F. AlshanonJamiyah HassanSazaly Abubakar & Won Fen Wong. (2022) Zika Virus Vaccine: The Current State of Affairs and Challenges Posed by Antibody-Dependent Enhancement Reaction. Viral Immunology 35:9, pages 586-596.
Crossref
Crossref
Olivia R. Brohlin, Ryanne N. Ehrman, Fabian C. Herbert, Yalini H. Wijesundara, Arun Raja, Arezoo Shahrivarkevishahi, Shashini D. Diwakara, Ronald A. Smaldone & Jeremiah J. Gassensmith. (2022) Zeolitic Imidazolate Framework Nanoencapsulation of CpG for Stabilization and Enhancement of Immunoadjuvancy. ACS Applied Nano Materials 5:10, pages 13697-13704.
Crossref
Crossref
Sofia A. Martins, Joana Santos, Rúben D. M. Silva, Cátia Rosa, Sandra Cabo Verde, João D. G. Correia & Rita Melo. (2022) How promising are HIV-1-based virus-like particles for medical applications. Frontiers in Cellular and Infection Microbiology 12.
Crossref
Crossref
Marianna Teixeira de Pinho Favaro, Jan Atienza-Garriga, Carlos Martínez-Torró, Eloi Parladé, Esther Vázquez, José Luis Corchero, Neus Ferrer-Miralles & Antonio Villaverde. (2022) Recombinant vaccines in 2022: a perspective from the cell factory. Microbial Cell Factories 21:1.
Crossref
Crossref
Sergio Morales-Hernández, Nerea Ugidos-Damboriena & Jacinto López-Sagaseta. (2022) Self-Assembling Protein Nanoparticles in the Design of Vaccines: 2022 Update. Vaccines 10:9, pages 1447.
Crossref
Crossref
Jorge L. Mejía-Méndez, Rafael Vazquez-Duhalt, Luis R. Hernández, Eugenio Sánchez-Arreola & Horacio Bach. (2022) Virus-like Particles: Fundamentals and Biomedical Applications. International Journal of Molecular Sciences 23:15, pages 8579.
Crossref
Crossref
Emily E Coates, Srilatha Edupuganti, Grace L Chen, Myra Happe, Larisa Strom, Alicia Widge, Maria Burgos Florez, Josephine H Cox, Ingelise Gordon, Sarah Plummer, Abidemi Ola, Galina Yamshchikov, Charla Andrews, Sharon Curate-Ingram, Patricia Morgan, Shashi Nagar, Matthew H Collins, Amy Bray, Thuy Nguyen, Judy Stein, Christopher L Case, Florence Kaltovich, Diane Wycuff, C Jason Liang, Kevin Carlton, Sandra Vazquez, John R Mascola, Julie E Ledgerwood, Ellie Butler, Jean Winter, Jianguo Xu, Amy Sherman, Colleen Kelley, Rameses Fredrick, Nadine Rouphael, Varun Phadke, Cynthia Whitney, Alicarmen Alvarez, Renata Dennis, Rebecca Fineman, Pamela Lankford-Turner, Sha Yi, Lilin Lai, Gena Burch, Shanker Gupta, Nina Berkowitz, Cristina Carter, Allison Beck, Brenda Larkin, Stephanie Taylor, Mandy Alger, Jessica Bahorich, Amy Lynch Chamberlain, Ya-chen Chang, Rajoshi Chaudhuri, Jonathan Cooper, Jacob Demirji, Fan Yang, Alissa Fernald, Deepika Gollapudi, Janel Holland-Linn, Lisa Kueltzo, James Lee, Jie Liu, Xun Liu, Rachel Mowery, Sarah O'Connell, Erwin Rosales-Zavala, Jason Sands, Xin Wang, Shaojie Weng & Sara Witter. (2022) Safety and immunogenicity of a trivalent virus-like particle vaccine against western, eastern, and Venezuelan equine encephalitis viruses: a phase 1, open-label, dose-escalation, randomised clinical trial. The Lancet Infectious Diseases 22:8, pages 1210-1220.
Crossref
Crossref
Lukas Gerstweiler, Jagan Billakanti, Jingxiu Bi & Anton P. J. Middelberg. (2022) An integrated and continuous downstream process for microbial virus‐like particle vaccine biomanufacture. Biotechnology and Bioengineering 119:8, pages 2122-2133.
Crossref
Crossref
Nura A. Mohamed, Haissam Abou-Saleh, Hana A. Mohamed, Mohammad A. Al-Ghouti, Sergio Crovella & Luisa Zupin. (2022) Think like a Virus: Toward Improving Nanovaccine Development against SARS-CoV-2. Viruses 14:7, pages 1553.
Crossref
Crossref
Sandhya Kalathilparambil Santhosh, Kaviya Parampath Kootery, Mridul Umesh, Preethi Mariam Alex, Meghna Mani, Adina Roy & Suma Sarojini. 2022. Nanovaccinology as Targeted Therapeutics. Nanovaccinology as Targeted Therapeutics
53
76
.
Fernando Alvarez, Roman Istomine, Hilary Hendin, Breanna Hodgins, Stephane Pillet, Jörg H. Fritz, Nathalie Charland, Brian J. Ward & Ciriaco A. Piccirillo. (2022) A Hemagglutinin 1 Carrying Plant-Based Virus-like Particle Vaccine Generates an Efficacious Cellular Response by Exploiting IL-1 Signaling in Both Adult and Aged Mice. ImmunoHorizons 6:6, pages 384-397.
Crossref
Crossref
Sheikh Saba Naz & Iqra Munir. (2022) An Outline of Contributing Vaccine Technologies for SARS CoV2
Advancing in Clinical and Preclinical Phase-Trials. Recent Patents on Biotechnology 16:2, pages 122-143.
Crossref
Crossref
Chunhong Dong & Bao-Zhong Wang. (2021) Engineered Nanoparticulate Vaccines to Combat Recurring and Pandemic Influenza Threats. Advanced NanoBiomed Research 2:3.
Crossref
Crossref
Reyad Almoheer, Mohd Effendy Abd Wahid, Hidayatul Aini Zakaria, Mohd Anuar Bin Jonet, Muhanna Mohammed Al-shaibani, Adel Al-Gheethi & Siti Nor Khadijah Addis. (2022) Spatial, Temporal, and Demographic Patterns in the Prevalence of Hemorrhagic Septicemia in 41 Countries in 2005–2019: A Systematic Analysis with Special Focus on the Potential Development of a New-Generation Vaccine. Vaccines 10:2, pages 315.
Crossref
Crossref
Tara Bhat, Amy Cao & John Yin. (2022) Virus-like Particles: Measures and Biological Functions. Viruses 14:2, pages 383.
Crossref
Crossref
Chunhong Dong, Ye Wang, Wandi Zhu, Yao Ma, Joo Kim, Lai Wei, Gilbert X. Gonzalez & Bao-Zhong Wang. (2022) Polycationic HA/CpG Nanoparticles Induce Cross-Protective Influenza Immunity in Mice. ACS Applied Materials & Interfaces 14:5, pages 6331-6342.
Crossref
Crossref
Eman A. Taha, Joseph Lee & Akitsu Hotta. (2022) Delivery of CRISPR-Cas tools for in vivo genome editing therapy: Trends and challenges. Journal of Controlled Release 342, pages 345-361.
Crossref
Crossref
Mona O. Mohsen, Ina Balke, Simon Zinkhan, Villija Zeltina, Xuelan Liu, Xinyue Chang, Pascal S. Krenger, Kevin Plattner, Zahra Gharailoo, Anne‐Cathrine S. Vogt, Gilles Augusto, Marianne Zwicker, Salony Roongta, Dominik A. Rothen, Romano Josi, Joana J. da Costa, Jan M. Sobczak, Aleksandra Nonic, Lee‐Anne Brand, Katja Nuss, Byron Martina, Daniel E. Speiser, Thomas Kündig, Gary T. Jennings, Senta M. Walton, Monique Vogel, Andris Zeltins & Martin F. Bachmann. (2021) A scalable and highly immunogenic virus‐like particle‐based vaccine against SARS‐CoV‐2. Allergy 77:1, pages 243-257.
Crossref
Crossref
Maryam Tabarzad, Elham Mohit & Fatemeh Ghorbani-Bidkorbeh. 2022. Emerging Nanomaterials and Nano-Based Drug Delivery Approaches to Combat Antimicrobial Resistance. Emerging Nanomaterials and Nano-Based Drug Delivery Approaches to Combat Antimicrobial Resistance
425
484
.
I. García-Silva, M. Colunga-Saucedo, C. Almendarez-Rodríguez, C. Miranda-López, S. Rosales-Mendoza & M. Comas-Garcia. 2022. Biomedical Innovations to Combat COVID-19. Biomedical Innovations to Combat COVID-19
173
192
.
Fabiana A Carneiro, Juliana dos Reis Cortines, Victor Alejandro Essus & Isis Botelho N da Silva. 2022. System Vaccinology. System Vaccinology
55
86
.
Zhian Chen, Xin Gao & Di Yu. (2022) Longevity of vaccine protection: Immunological mechanism, assessment methods, and improving strategy. VIEW 3:1.
Crossref
Crossref
Alina Popa & Sebastian Springer. (2021) Tailored Nanoparticles as Vaccine Components. Applied Sciences 11:24, pages 11898.
Crossref
Crossref
Ana Sara Cordeiro, Yogita Patil-Sen, Maitreyi Shivkumar, Ronak Patel, Abdulwahhab Khedr & Mohamed A. Elsawy. (2021) Nanovaccine Delivery Approaches and Advanced Delivery Systems for the Prevention of Viral Infections: From Development to Clinical Application. Pharmaceutics 13:12, pages 2091.
Crossref
Crossref
Ángel de Jesús Jiménez-Chávez, Brenda Katherine Nava-García, Ismael Bustos-Jaimes & Leticia Moreno-Fierros. (2021) B19-VLPs as an effective delivery system for tumour antigens to induce humoral and cellular immune responses against triple negative breast cancer. Immunology Letters 239, pages 77-87.
Crossref
Crossref
Irene González-Domínguez, Elianet Lorenzo, Alice Bernier, Laura Cervera, Francesc Gòdia & Amine Kamen. (2021) A Four-Step Purification Process for Gag VLPs: From Culture Supernatant to High-Purity Lyophilized Particles. Vaccines 9:10, pages 1154.
Crossref
Crossref
Gabriella Marfe, Stefania Perna & Arvind Shukla. (2021) Effectiveness of COVID‑19 vaccines and their challenges (Review). Experimental and Therapeutic Medicine 22:6.
Crossref
Crossref
Ester Calvo Fernández & Lucie Y. Zhu. (2021) Racing to immunity: Journey to a COVID‐19 vaccine and lessons for the future. British Journal of Clinical Pharmacology 87:9, pages 3408-3424.
Crossref
Crossref
Pin-Yu Perera & Liyanage P. Perera. (2021) Development of leading first-generation vaccines against SARS-CoV-2. Microbes and Infection 23:8, pages 104841.
Crossref
Crossref
Shai Zilberzwige-Tal, Dan Mark Alon, Danielle Gazit, Shahar Zachariah, Amit Hollander, Ehud Gazit & Johann Elbaz. (2021) Genetically Encoding Ultrastable Virus-like Particles Encapsulating Functional DNA Nanostructures in Living Bacteria. ACS Synthetic Biology 10:8, pages 1798-1807.
Crossref
Crossref
Shi‐Jian Song, Gyeong‐Im Shin, Jinyong Noh, Jiho Lee, Deok‐Hwan Kim, Gyeongryul Ryu, Gyeongik Ahn, Hyungmin Jeon, Hai‐Ping Diao, Youngmin Park, Min Gab Kim, Woe‐Yeon Kim, Young‐Jin Kim, Eun‐Ju Sohn, Chang Seon Song & Inhwan Hwang. (2021)
Plant‐based, adjuvant‐free, potent multivalent vaccines for avian influenza virus via
Lactococcus
surface display
. Journal of Integrative Plant Biology 63:8, pages 1505-1520.
Crossref
Crossref
Maryam Bayat, Yahya Asemani & Sajad Najafi. (2021) Essential considerations during vaccine design against COVID-19 and review of pioneering vaccine candidate platforms. International Immunopharmacology 97, pages 107679.
Crossref
Crossref
Nikole L. Warner & Kathryn M. Frietze. (2021) Development of Bacteriophage Virus-Like Particle Vaccines Displaying Conserved Epitopes of Dengue Virus Non-Structural Protein 1. Vaccines 9:7, pages 726.
Crossref
Crossref
Aline Maria Vasconcelos Queiroz, Yulia Aleksandrovna Yanshina, Emily Thays da Silva Rodrigues, Fred Luciano Neves Santos, Paola Alejandra Fiorani Celedon, Sweta Maheshwari, Sandra Beatriz Gabelli, Carla Stephanie Peucelle Rubio, Aritz Durana, Diego M.A. Guérin & Marcelo Sousa Silva. (2021) Antibodies response induced by recombinant virus-like particles from Triatoma virus and chimeric antigens from Trypanosoma cruzi. Vaccine 39:33, pages 4723-4732.
Crossref
Crossref
Velasco Cimica, Sahar Saleem, Emily Matuczinski, Debra Adams-Fish, Conor McMahon, Sujatha Rashid & Timothy Stedman. (2021) A Virus-Like Particle-Based Vaccine Candidate against the Tick-Borne Powassan Virus Induces Neutralizing Antibodies in a Mouse Model. Pathogens 10:6, pages 680.
Crossref
Crossref
Benjamin Cossette, Sean H. Kelly & Joel H. Collier. (2020) Intranasal Subunit Vaccination Strategies Employing Nanomaterials and Biomaterials. ACS Biomaterials Science & Engineering 7:5, pages 1765-1779.
Crossref
Crossref
Young-Il Kim, Dokyun Kim, Kwang-Min Yu, Hogyu David Seo, Shin-Ae Lee, Mark Anthony B. Casel, Seung-Gyu Jang, Stephanie Kim, WooRam Jung, Chih-Jen Lai, Young Ki Choi & Jae U. Jung. (2021) Development of Spike Receptor-Binding Domain Nanoparticles as a Vaccine Candidate against SARS-CoV-2 Infection in Ferrets. mBio 12:2.
Crossref
Crossref
Virgil Schijns, Dragomira Majhen, Peter van der Ley, Aneesh Thakur, Artur Summerfield, Rita Berisio, Cristina Nativi, Alberto Fernández-Tejada, Carmen Alvarez-Dominguez, Sveinbjörn Gizurarson, Alla Zamyatina, Antonio Molinaro, Camillo Rosano, Žiga Jakopin, Ihsan Gursel & Siobhán McClean. (2021) Rational Vaccine Design in Times of Emerging Diseases: The Critical Choices of Immunological Correlates of Protection, Vaccine Antigen and Immunomodulation. Pharmaceutics 13:4, pages 501.
Crossref
Crossref
Rula M. Darwish. (2021) COVID-19 immunity and vaccines: what a pharmacist needs to know. Asian Biomedicine 15:2, pages 51-67.
Crossref
Crossref
Lukas Gerstweiler, Jingxiu Bi & Anton Peter Jacob Middelberg. (2021) Virus‐like particle preparation is improved by control over capsomere‐DNA interactions during chromatographic purification. Biotechnology and Bioengineering 118:4, pages 1688-1701.
Crossref
Crossref
Sukanya Ghosh & Manidipa Banerjee. (2021) A smart viral vector for targeted delivery of hydrophobic drugs. Scientific Reports 11:1.
Crossref
Crossref
Kailash C. Petkar, Suyash M. Patil, Sandip S. Chavhan, Kan Kaneko, Krutika K. Sawant, Nitesh K. Kunda & Imran Y. Saleem. (2021) An Overview of Nanocarrier-Based Adjuvants for Vaccine Delivery. Pharmaceutics 13:4, pages 455.
Crossref
Crossref
Diego Fontana, Ernesto Garay, Laura Cervera, Ricardo Kratje, Claudio Prieto & Francesc Gòdia. (2021) Chimeric VLPs Based on HIV-1 Gag and a Fusion Rabies Glycoprotein Induce Specific Antibodies against Rabies and Foot-and-Mouth Disease Virus. Vaccines 9:3, pages 251.
Crossref
Crossref
S. A. Cherepushkin, V. V. Tsibezov, A. G. Yuzhakov, O. E. Latyshev, K. P. Alekseev, E. G. Altayeva, K. M. Khametova, G. K. Vorkunova, K. A. Yuzhakova & T. V. Grebennikova. (2021) Synthesis and characterization of human rotavirus A (<i>Reoviridae: Sedoreovirinae: Rotavirus: Rotavirus A</i>) virus-like particles. Problems of Virology 66:1, pages 55-64.
Crossref
Crossref
Sasheen Dowlath, Katrin Campbell, Farah Al-Barwani, Vivienne L. Young, Sarah L. Young, Greg F. Walker & Vernon K. Ward. (2021) Dry Formulation of Virus-Like Particles in Electrospun Nanofibers. Vaccines 9:3, pages 213.
Crossref
Crossref
Jee Young Chung, Melissa N. Thone & Young Jik Kwon. (2021) COVID-19 vaccines: The status and perspectives in delivery points of view. Advanced Drug Delivery Reviews 170, pages 1-25.
Crossref
Crossref
Saghi Nooraei, Howra Bahrulolum, Zakieh Sadat Hoseini, Camellia Katalani, Abbas Hajizade, Andrew J. Easton & Gholamreza Ahmadian. (2021) Virus-like particles: preparation, immunogenicity and their roles as nanovaccines and drug nanocarriers. Journal of Nanobiotechnology 19:1.
Crossref
Crossref
Lukas Gerstweiler, Jagan Billakanti, Jingxiu Bi & Anton Middelberg. (2021) Comparative evaluation of integrated purification pathways for bacterial modular polyomavirus major capsid protein VP1 to produce virus-like particles using high throughput process technologies. Journal of Chromatography A 1639, pages 461924.
Crossref
Crossref
Shrina P. Patel, Gayatri S. Patel & Jalpa V. Suthar. (2021) Inside the story about the research and development of COVID-19 vaccines. Clinical and Experimental Vaccine Research 10:2, pages 154.
Crossref
Crossref
Fataneh Fatemi, Zahra Hassani Nejad & Seyed Ehsan Ranaei Siadat. 2021. COVID-19. COVID-19
149
185
.
Yu Tao, Rui Yang, Jianhong Shu, Wenqian Zheng, Jian Chen, Yuehong Wu & Yulong He. (2020) Immune responses induced by a combined vaccination with a recombinant chimera of Mycoplasma hyopneumoniae antigens and capsid virus-like particles of porcine circovirus type 2. BMC Veterinary Research 16:1.
Crossref
Crossref
Mateusz Marchel, Joanna Niewisiewicz, Ana S. Coroadinha & Isabel M. Marrucho. (2020) Purification of virus-like particles using aqueous biphasic systems composed of natural deep eutectic solvents. Separation and Purification Technology 252, pages 117480.
Crossref
Crossref
Swarnendu Basak, Ki-Back Chu, Hae-Ji Kang, Min-Ju Kim, Su-Hwa Lee, Keon-Woong Yoon, Hui Jin, Joo Won Suh, Eun-Kyung Moon & Fu-Shi Quan. (2020) Orally administered recombinant baculovirus vaccine elicits partial protection against avian influenza virus infection in mice. Microbial Pathogenesis 149, pages 104495.
Crossref
Crossref
Keman Cheng, Qinglin Kang & Xiao Zhao. (2020) Biogenic nanoparticles as immunomodulator for tumor treatment. WIREs Nanomedicine and Nanobiotechnology 12:6.
Crossref
Crossref
Woo Sik Kim, Yong Zhi, Huichen Guo, Eui-Baek Byun, Jae Hyang Lim & Ho Seong Seo. (2020) Promotion of Cellular and Humoral Immunity against Foot-and-Mouth Disease Virus by Immunization with Virus-Like Particles Encapsulated in Monophosphoryl Lipid A and Liposomes. Vaccines 8:4, pages 633.
Crossref
Crossref
Mangalakumari Jeyanathan, Sam Afkhami, Fiona Smaill, Matthew S. Miller, Brian D. Lichty & Zhou Xing. (2020) Immunological considerations for COVID-19 vaccine strategies. Nature Reviews Immunology 20:10, pages 615-632.
Crossref
Crossref
Eduard Puente‐Massaguer, Paolo Saccardo, Neus Ferrer‐Miralles, Martí Lecina & Francesc Gòdia. (2020) Coupling Microscopy and Flow Cytometry for a Comprehensive Characterization of Nanoparticle Production in Insect Cells. Cytometry Part A 97:9, pages 921-932.
Crossref
Crossref
Hannah G. Kelly, Hyon-Xhi Tan, Jennifer A. Juno, Robyn Esterbauer, Yi Ju, Wenbo Jiang, Verena C. Wimmer, Brigette C. Duckworth, Joanna R. Groom, Frank Caruso, Masaru Kanekiyo, Stephen J. Kent & Adam K. Wheatley. (2020) Self-assembling influenza nanoparticle vaccines drive extended germinal center activity and memory B cell maturation. JCI Insight 5:10.
Crossref
Crossref
Huapeng Feng, Sumiho Nakatsu, Tiago Jose da Silva Lopes, Masaki Imai, Seiya Yamayoshi, Makoto Yamashita, Tokiko Watanabe & Yoshihiro Kawaoka. (2020) Identification of Novel Adjuvants for Ebola Virus-Like Particle Vaccine. Vaccines 8:2, pages 215.
Crossref
Crossref
Sigridur Jonsdottir, Victoria Fettelschoss, Florian Olomski, Stephanie C. Talker, Jelena Mirkovitch, Tanya Rhiner, Katharina Birkmann, Franziska Thoms, Bettina Wagner, Martin F. Bachmann, Thomas M. Kündig, Eliane Marti & Antonia Fettelschoss-Gabriel. (2020) Safety Profile of a Virus-Like Particle-Based Vaccine Targeting Self-Protein Interleukin-5 in Horses. Vaccines 8:2, pages 213.
Crossref
Crossref
Paul L. Chariou, Oscar A. Ortega-Rivera & Nicole F. Steinmetz. (2020) Nanocarriers for the Delivery of Medical, Veterinary, and Agricultural Active Ingredients. ACS Nano 14:3, pages 2678-2701.
Crossref
Crossref
Eduard Puente-Massaguer, Martí Lecina & Francesc Gòdia. (2020) Application of advanced quantification techniques in nanoparticle-based vaccine development with the Sf9 cell baculovirus expression system. Vaccine 38:7, pages 1849-1859.
Crossref
Crossref
Bryce Chackerian & David S. Peabody. (2020) Factors That Govern the Induction of Long-Lived Antibody Responses. Viruses 12:1, pages 74.
Crossref
Crossref
Darrell J. Irvine, Aereas Aung & Murillo Silva. (2020) Controlling timing and location in vaccines. Advanced Drug Delivery Reviews 158, pages 91-115.
Crossref
Crossref
David Wetzel, Andreas Barbian, Volker Jenzelewski, Gerhard Schembecker, Juliane Merz & Michael Piontek. (2019) Bioprocess optimization for purification of chimeric VLP displaying BVDV E2 antigens produced in yeast Hansenula polymorpha. Journal of Biotechnology 306, pages 203-212.
Crossref
Crossref
Patricia Pereira Aguilar, Tobias Amadeus Schneider, Viktoria Wetter, Daniel Maresch, Wai Li Ling, Andres Tover, Petra Steppert & Alois Jungbauer. (2019) Polymer-grafted chromatography media for the purification of enveloped virus-like particles, exemplified with HIV-1 gag VLP. Vaccine 37:47, pages 7070-7080.
Crossref
Crossref
Mateusz Marchel, Hugo R. Soares, Philipp Vormittag, Jürgen Hubbuch, Ana S. Coroadinha & Isabel M. Marrucho. (2019) High‐throughput screening of aqueous biphasic systems with ionic liquids as additives for extraction and purification of enveloped virus‐like particles. Engineering Reports 1:1.
Crossref
Crossref
Sergio Rosales-Mendoza & Omar González-OrtegaSergio Rosales-Mendoza & Omar González-Ortega. 2019. Nanovaccines. Nanovaccines
267
318
.